Comparison of sequence listing requirements in divisional patent applications between EPO and BRPTO.

Government issues guidelines for the IP strategy from 2023-2025 in Brazil, focusing on innovation

ANVISA’s new regulations aiming to implement “skinny labels” for generic drugs in Brazil

Brazil’s plans to introduce “skinny labels” for generic drugs, impacting pharmaceutical patents

Criticism of Brazilian Patent Office’s recent rule changes impacting appeals and examinations

Brazilian Patent Office’s efforts to harmonize patent practices and reduce backlog

Challenges in securing IP protection, particularly for divisionals in the Brazilian market

Examines upcoming legal challenges posed by advances in AI and quantum computing

Legislative proposal allowing AI to be recognized as inventors in patent applications in Brazil

Updates on new regulations impacting patent appeals and examinations in Brazil

Proposal introduced to allow AI as an inventor in patent filings in Brazil, sparking debate

Rapid growth of Brazil’s medical device market has led to increased patent infringement challenges

Explores patent litigation in Brazil’s growing animal health sector, emphasizing legal challenges

Ongoing efforts and innovations in global vaccine development, focusing on emerging technologies

Encourages sustainable innovation by expediting environmentally friendly patent applications’ examination in Brazil